Inventor · disambiguated record
Yong He
Also filed as: HE YONG · He yong lin
73 granted patents·30 pending applications·294 citations·filing 2005–2025
99Inventor score
Top patents by PatentIndex Score
103 records- 0198US11560368B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2021·Granted Jan 24, 2023·6 cites·18 claims
- 0298US11384090B2Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2021·Granted Jul 12, 2022·14 cites·15 claims
- 0398US11352363B1Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2021·Granted Jun 7, 2022·13 cites·9 claims
- 0498US11325916B1Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2021·Granted May 10, 2022·16 cites·15 claims
- 0598US10683279B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2018·Granted Jun 16, 2020·13 cites·18 claims
- 0697US11420976B2Heterocyclic compounds as anti-viral agentsENANTA PHARM INC·Filed 2021·Granted Aug 23, 2022·7 cites·23 claims
- 0797US10988458B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2020·Granted Apr 27, 2021·7 cites·23 claims
- 0896US11919910B2Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2022·Granted Mar 5, 2024·5 cites·13 claims
- 0995US10676500B2Process for preparation of sulfonyl carbamate bile acid derivativesENANTA PHARM INC·Filed 2018·Granted Jun 9, 2020·7 cites·8 claims
- 1095US10584145B2Process for preparation of sulfonylurea bile acid derivativesENANTA PHARM INC·Filed 2017·Granted Mar 10, 2020·8 cites·14 claims
- 1195US10450301B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2018·Granted Oct 22, 2019·11 cites·20 claims
- 1295US10246439B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2018·Granted Apr 2, 2019·12 cites·20 claims
- 1394US12018017B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2022·Granted Jun 25, 2024·1 cites·14 claims
- 1494US11834436B2Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2021·Granted Dec 5, 2023·2 cites·5 claims
- 1594US10253018B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2018·Granted Apr 9, 2019·10 cites·26 claims
- 1693US8809314B1Cephalosporin compoundCUBIST PHARM INC·Filed 2013·Granted Aug 19, 2014·16 cites·7 claims
- 1790US9130711B2Mapping signals from a virtual frequency band to physical frequency bandsHE YONG·Filed 2011·Granted Sep 8, 2015·17 cites·19 claims
- 1889US8929933B2Spectrum allocation for base stationTAN KUN·Filed 2011·Granted Jan 6, 2015·9 cites·20 claims
- 1988US10080743B2Isoxazole derivatives as FXR agonists and methods of use thereofENANTA PHARM INC·Filed 2017·Granted Sep 25, 2018·4 cites·22 claims
- 2088US8962843B21,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Feb 24, 2015·3 cites·5 claims
- 2188US8254622B2Portable electronic device with detachable speakerJIANG BIN·Filed 2010·Granted Aug 28, 2012·14 cites·8 claims
- 2287US10080742B2Isoxazole derivatives as FXR agonists and methods of use thereofENANTA PHARM INC·Filed 2017·Granted Sep 25, 2018·3 cites·24 claims
- 2387US8173753B2Method for producing aliphatic polyester resin, and an aliphatic polyester resin compositionNAGANO TATSUYA·Filed 2009·Granted May 8, 2012·18 cites·13 claims
- 2486US8916709B21,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Dec 23, 2014·4 cites·20 claims
- 2586US7944940B2Method and apparatus for media access in contention-based networksTHOMSON LICENSING·Filed 2007·Granted May 17, 2011·13 cites·12 claims
- 2685US10149835B2Isoxazole derivatives as FXR agonists and methods of use thereofENANTA PHARM INC·Filed 2017·Granted Dec 11, 2018·2 cites·18 claims
- 2785US10080741B2Isoxazole derivatives as FXR agonists and methods of use thereofENANTA PHARM INC·Filed 2017·Granted Sep 25, 2018·3 cites·19 claims
- 2884US12459923B2Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2023·Granted Nov 4, 2025·0 cites·12 claims
- 2983US9850716B2Remote-controlled adjustable-speed screw drill for gas-drive hydraulic-motive during gas drillingUNIV SOUTHWEST PETROLEUM·Filed 2016·Granted Dec 26, 2017·6 cites·9 claims
- 3083US8969570B2Beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Mar 3, 2015·3 cites·15 claims
- 3182US12124963B2Disentangled personalized federated learning method via consensus representation extraction and diversity propagationINST AUTOMATION CAS·Filed 2024·Granted Oct 22, 2024·1 cites·9 claims
- 3282US8940897B21,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Jan 27, 2015·1 cites·5 claims
- 3382US8933233B21,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Jan 13, 2015·1 cites·5 claims
- 3482US8933232B21,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Jan 13, 2015·1 cites·5 claims
- 3582US8927724B2Isoxazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Jan 6, 2015·3 cites·39 claims
- 3681US11008304B2Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2019·Granted May 18, 2021·1 cites·6 claims
- 3781US8962844B21,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Feb 24, 2015·1 cites·5 claims
- 3881US8693380B2Method and apparatus for power management in WLANHE YONG·Filed 2007·Granted Apr 8, 2014·10 cites·18 claims
- 3980US10144729B2Isoxazole analogs as FXR agonists and methods of use thereofENANTA PHARM INC·Filed 2017·Granted Dec 4, 2018·2 cites·20 claims
- 4079US10143957B2High-efficiency gradient hierarchy complex desulfurizing towerHUANENG POWER INT INC·Filed 2016·Granted Dec 4, 2018·3 cites·14 claims
- 4177US9918313B2Spectrum allocation for base stationMICROSOFT TECHNOLOGY LICENSING LLC·Filed 2014·Granted Mar 13, 2018·3 cites·17 claims
- 4274US10138228B2Isoxazole derivatives as FXR agonists and methods of use therofENANTA PHARM INC·Filed 2017·Granted Nov 27, 2018·1 cites·18 claims
- 4374US8755281B2Constant window back-off method for multiple access in wireless local area networksHE YONG·Filed 2010·Granted Jun 17, 2014·3 cites·12 claims
- 4472US2015031659A11,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2014·Application pending·0 cites
- 4572US2025120412A1Multi-layer fermentation tank for tea leaves and use method thereofUNIV ZHEJIANG·Filed 2024·Application pending·0 cites
- 4671US12384753B217-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2022·Granted Aug 12, 2025·0 cites·6 claims
- 4771US7229996B2Rifamycin derivativesCUMBRE PHARMACEUTICALS INC·Filed 2005·Granted Jun 12, 2007·1 cites·8 claims
- 4871US7226931B2(R/S) rifamycin derivatives, their preparations and pharmaceutical compositionsCUMBRE PHARMACEUTICALS INC·Filed 2005·Granted Jun 5, 2007·1 cites·15 claims
- 4970US2025376452A117-Beta-Hydroxysteroid Dehydrogenase Type 13 Inhibitors and Methods of Use ThereofENANTA PHARM INC·Filed 2025·Application pending·0 cites
- 5069US8570986B2Semi-random back-off method for achieving resource reservation in wireless local area networksHE YONG·Filed 2010·Granted Oct 29, 2013·2 cites·6 claims
Showing the top 50 of 103 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yong He files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →